|
Market Closed -
Nasdaq
04:30:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.400 USD | -11.37% |
|
-13.56% | -94.04% |
| 10-10 | BioRestorative Therapies, Inc. Announces Board and Committee Changes | CI |
| 10-06 | Maxim Downgrades BioRestorative Therapies to Hold From Buy | MT |
Company Valuation: BioRestorative Therapies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 1.784 | - | - |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -82.9% | - | - |
| Enterprise Value (EV) | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 1.784 | 1.784 | 1.784 |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -82.9% | 0% | 0% |
| P/E | -0.12x | -0.54x | -0.51x | -1.23x | -0.74x | -0.11x | -0.13x | -0.14x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | -0x | 0x | 0x | 0.02x |
| Capitalization / Revenue | 330x | 84.3x | 56.2x | 24.7x | 29x | 5.75x | 1.19x | 0.71x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 5.75x | 1.19x | 0.71x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.11x | -0.11x | -0.11x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -746 | -102.2 | -68.4 | -23.2 | -31.6 | -13.2 | -10.4 | -9.8 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.046 | 0.1198 | 0.1458 | 0.401 | 0.3597 | 0.31 | 1.5 | 2.5 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -26.31 | -18.97 | -15.22 | -11.56 | -15.65 | -16.82 | -16.54 | -16.48 |
| Net income 1 | -44.3 | -18.49 | -14.42 | -8.979 | -14.24 | -16.64 | -16.32 | -16.2 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 86.800 | 55.000 | 34.798 | 28.600 | 23.500 | 1.400 | 1.400 | 1.400 |
| Nbr of stocks (in thousands) | 175 | 184 | 235 | 346 | 444 | 1,274 | - | - |
| Announcement Date | 30/3/22 | 27/3/23 | 1/4/24 | 28/3/25 | 26/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11x | - | - | - | 1.78M | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -71.62x | 13.03x | -68.47x | -.--% | 24.7B | |
| Average | 15.59x | 28.01x | 7.09x | 0.34% | 39.43B | |
| Weighted average by Cap. | 21.64x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRTX Stock
- Valuation BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
